澳洲幸运八体彩官方开奖 澳洲8官方开奖官网结果 历史开奖记录 现场直播查询. Your Research Partner in the Fight Against Cancer

We advance your clinical trials with our statistical and data management solutions and 25+ years of clinical trial expertise. About CRAB

Who We Help

Cancer researcher

Cancer Researchers

We have experienced biostatisticians and data scientists who collaborate on study design, data analysis, and interpretation. We help your researchers develop and implement robust statistical methods, ensuring findings are accurate, reliable, and generalizable.

Learn More

electron microcope cancer image

Pharmaceutical & Biotech Companies

Cancer Research And Biostatistics (CRAB) works directly with companies to design and conduct clinical trials, providing expertise in biostatistics, data analysis, and study design. This will help your company develop more effective and targeted therapies.

Learn More

National Cancer Institute sign

NIH-funded Projects

CRAB has contributed to NIH funded projects for 25+ years. In partnership with Fred Hutch Cancer Research Center, CRAB is also a part of the Statistics and Data Management Center for both the SWOG Cancer Research Network and Cancer Screening Research Network (CSRN).

Learn More

How We Help

biostats-homepage-feature-400x150-1

Biostatistics

We design and analyze of a wide variety of oncology clinical trials. Trials range from Phase I single or multi-institution industry sponsored to Phase III multi-institutional trials.
More About Biostatistic Services

edc-homepage-feature-400x150-1

Electronic Data Capture (EDC)

We securely capture, store, analyze and report research data in multiple EDC systems, including Medidata Rave and our own CRAB Nebula™ EDC.

More About EDCs

datamgmt-homepage-feature-400x150-1

Data Management

CRAB provides expert data collection, management and quality services, crucial to quality research and science.

More About Data Management

Our Expertise

Clinical Trial Expertise from Statistics to Data Collection and Management

Photo of John Crowley, Antje Hoering celebrating CRAB's 25th anniversary
Founder John Crowley and CEO Antje Hoering

CRAB was founded 25 years ago to play a unique and critical role in the battle against cancer.

Our commitment to prevent and cure cancer is reflected in our approach to clinical research. As a nonprofit organization focused on cancer research, we provide accurate, timely, objective, independent results to our clients.

CRAB has a team of dedicated, talented statisticians, project managers, data monitors, application developers, and regulatory affairs personnel who provide the expertise to fulfill our mission and serve our clients.

Graphic of CRAB expertise by cancer type

Partner with CRAB

CRAB's expertise in biostatistics, data management, application development and DMC statistical and meeting management provides reliable and defensible results for your clinical trial.

 

Research

CRAB has supported more than 300 adult clinical trials. Many of the trials conducted through CRAB have been in large-scale Phase III trials. We have expertise across all trial phases including multi-institutional Phase I trials. The other studies (15%) are comprised of biological correlative studies, registries, post-marketing trials and outcomes research. CRAB statisticians have decades of experience in the design and analysis of a wide variety of oncology clinical trials. 

Diagram of clinical trial experience by trial phase

Collaborations

CRAB achieves its mission through long-standing partnerships with both research collaborators and with for-profit organizations. The SWOG Statistics and Data Management Center (SDMC) is co-located at Fred Hutch and CRAB. SWOG is one of five U.S.-based National Cancer Institute-supported cooperative groups within the National Clinical Trials Network (NCTN). CRAB’s Clinical Research Services (CRS) division has a number of key partnerships with research consortia as well as pharmaceutical clients. Other important collaborations for CRAB are with Friends of Cancer Research (Friends) and the International Association For The Study Of Lung Cancer (IASLC).